The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia
Open accessAbstract
Author(s): Reus, Victor I; Fochtmann, Laura J; Eyler, A Evan; Hilty, Donald M; Horvitz-Lennon, Marcela; Jibson, Michael D; Lopez, Oscar L; Mahoney, Jane; Pasic, Jagoda; Tan, Zaldy S; Wills, Cheryl D; Rhoads, Richard; Yager, Joel
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A vast number of guidelines and regulations to reduce inappropriate prescribing in older patients have been developed.
“A vast number of guidelines and regulations to reduce inappropriate prescribing in older patients have been developed [26–28].”
From Stakeholders' views on the use of psychotropic medication in older people: a systematic review (2022) · cites this paper as [27]
The Introduction describes this as a guideline for the judicious use of antipsychotics in patients with dementia, and the Guideline Statements recommend limiting their use in specified circumstances. It therefore supports the existence of a prescribing guideline, but does not establish that a vast number of guidelines and regulations have been developed for older patients generally. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285 · see citing works
Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K. C., Meerpohl, J. J., Alonso‐Coello, P., Rind, D. M., Montori, V. M., Brito, J. P., Norris, S. L., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,332 · see citing works
Assessment and management of behavioral and psychological symptoms of dementia
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ · doi:10.1136/bmj.h369 · Cited by 1,247 · see citing works
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
Guyatt, G., Gutterman, D., Baumann, M. H., Addrizzo-Harris, D., Hylek, E. M., Phillips, B., Raskob, G., Lewis, S. Z., & Schünemann, H. (2006) · Chest · doi:10.1378/chest.129.1.174 · Cited by 1,220 · see citing works
Shiffman, R. N., Dixon, J. K., Brandt, C., Essaihi, A., Hsiao, A., Michel, G., & O’Connell, R. T. (2005) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-5-23 · Cited by 389 · see citing works
Don't use antipsychotics routinely to treat agitation and aggression in people with dementia
Corbett, A., Burns, A. S., & Ballard, C. G. (2014) · BMJ · doi:10.1136/bmj.g6420 · Cited by 86 · see citing works
The Endocrine Society Guidelines: When the Confidence Cart Goes Before the Evidence Horse
Brito, J. P., Domecq, J. P., Murad, M. H., Guyatt, G. H., & Montori, V. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1814 · Cited by 74 · see citing works
Impact of quality of evidence on the strength of recommendations: an empirical study
Djulbegović, B., Trikalinos, T. A., Roback, J. D., Chen, R., & Guyatt, G. H. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-120 · Cited by 48 · see citing works
A guide to GRADE guidelines for the readers of JTH
Guyatt, G. H., Eikelboom, J. W., Akl, E. A., Crowther, M. A., Gutterman, D. D., Kahn, S. R., Schünemann, H. J., & Hirsh, J. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12320 · Cited by 47 · see citing works
A comparative quality assessment of evidence‐based clinical guidelines in endocrinology
Hazlehurst, J., Armstrong, M. J., Sherlock, M., Rowe, I. A. C., O’Reilly, M., Franklyn, J. A., Stewart, P. M., & Tomlinson, J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04441.x · Cited by 44 · see citing works
Yager, J., Kunkle, R., Fochtmann, L. J., Reid, S. M., Plovnick, R. M., Nininger, J. E., Silverman, J. J., & Vergare, M. J. (2014) · Academic Psychiatry · doi:10.1007/s40596-014-0046-6 · Cited by 20 · see citing works
Self-citation008 Principles for the Development of Specialty Society Clinical Guidelines
Fulda, G. J., Wolfkiel, C. J., Begolka, W. S., Campos‐Outcalt, D., Groman, R. F., Rubin, K., Davidson, C., May, C., Starkey, M., & Qaseem, A. (2013) · BMJ Quality & Safety · doi:10.1136/bmjqs-2013-002293.39 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
New evidence on the management of Lewy body dementia
Taylor, J.-P., McKeith, I. G., Burn, D. J., Boeve, B. F., Weintraub, D., Bamford, C., Allan, L. M., Thomas, A. J., & O'Brien, J. T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30153-x · Cited by 347 · see citing works
Management of Behavioral and Psychological Symptoms of Dementia
Bessey, L. J., & Walaszek, A. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1049-5 · Cited by 288 · see citing works
Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses
Tampi, R. R., Tampi, D. J., Balachandran, S., & Srinivasan, S. (2016) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622316658463 · Cited by 267 · see citing works
Grossberg, G. T., Kohegyi, E., Mergel, V., Josiassen, M. K., Meulien, D., Hobart, M., Slomkowski, M., Baker, R. A., McQuade, R. D., & Cummings, J. L. (2020) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.09.009 · Cited by 169 · see citing works
Trial of pimavanserin in dementia-related psychosis
Tariot, P. N., Cummings, J. L., Soto-Martin, M. E., Ballard, C., Erten-Lyons, D., Sultzer, D. L., Devanand, D. P., Weintraub, D., McEvoy, B., Youakim, J. M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034634 · Cited by 145 · see citing works
Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial
Lee, D., Slomkowski, M., Hefting, N., Chen, D., Larsen, K. G., Kohegyi, E., Hobart, M., Cummings, J. L., & Grossberg, G. T. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.3810 · Cited by 135 · see citing works
Antipsychotic Use in Dementia: Is There a Problem and Are There Solutions?
Kirkham, J., Sherman, C., Velkers, C., Maxwell, C., Gill, S., Rochon, P., & Seitz, D. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716673321 · Cited by 113 · see citing works
Caregiver perspectives about using antipsychotics and other medications for symptoms of dementia
Kerns, J. W., Winter, J. D., Winter, K. M., Kerns, C. C., & Etz, R. S. (2018) · The Gerontologist · doi:10.1093/geront/gnx042 · Cited by 62 · see citing works
Advances in treatment of frontotemporal dementia
Magrath Guimet, N., Zapata-Restrepo, L. M., & Miller, B. L. (2022) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.21060166 · Cited by 52 · see citing works
Aigbogun, M. S., Stellhorn, R., Hartry, A., Baker, R. A., & Fillit, H. (2019) · BMC Neurology · doi:10.1186/s12883-019-1260-3 · Cited by 46 · see citing works
Walsh, K. A., Sinnott, C., Fleming, A., Mc Sharry, J., Byrne, S., Browne, J., & Timmons, S. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.07.004 · Cited by 37 · see citing works
Teixeira, A. L., Rocha, N. P., & Gatchel, J. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1777774 · Cited by 33 · see citing works
Stakeholders' views on the use of psychotropic medication in older people: a systematic review
Bednarczyk, E., Cook, S., Brauer, R., & Garfield, S. (2022) · Age and Ageing · doi:10.1093/ageing/afac060 · Cited by 22 · see citing works
Lornstad, M. T., Aarøen, M., Bergh, S., Benth, J. Š., & Helvik, A.-S. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1126-y · Cited by 24 · see citing works
Brexpiprazole for the Treatment of Agitation and Aggression in Alzheimer Disease
Ballard, C. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.3967 · Cited by 14 · see citing works
Are We Getting Better at Managing Agitation in Dementia?
Almeida, O. P., & Ford, A. H. (2020) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.11.004 · Cited by 4 · see citing works
- Authors
- Reus, V. I., Fochtmann, L. J., Eyler, A. E., Hilty, D. M., Horvitz-Lennon, M., Jibson, M. D., Lopez, O. L., Mahoney, J., Pasic, J., Tan, Z. S., Wills, C. D., Rhoads, R., & Yager, J.
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2016-05-01
- Volume
- 173
- Issue
- 5
- Pages
- 543-546
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2344518133
- Cited by
- 441
- References
- 12
- Citations by year
- 2026: 30 · 2025: 27 · 2024: 59 · 2023: 37 · 2022: 44 · 2021: 53 · 2020: 58 · 2019: 50 · 2018: 44 · 2017: 30 · 2016: 8
- FWCI
- 38.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- antipsychotic drugs, dementia, agitation, psychosis, treatment guidelines, psychotropic drug use, behavioral symptoms of dementia
- MeSH terms
- Consensus Statements as Topic, Dementia, Humans, Psychomotor Agitation, Psychotic Disorders, Antipsychotic Agents, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
